# Omzo reviews (2026): GLP-1 telehealth sellers | This GLP

Two GLP-1 rates are published, and four of the six advertised categories are not open yet.

Publisher: This GLP Editorial Team
Canonical: https://thisglp.com/reviews/omzo
Updated: 2026-10-28

By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 A catalog still being built

# Omzo review

Two GLP-1 rates are published, and four of the six advertised categories are not open yet.

## The verdict

Omzo prices compounded semaglutide at $179 a month and compounded tirzepatide at $279. The medication cost sits inside that fee. A branded prescription, if written instead, is the patient's to fill and fund.

**Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures).

Category

GLP-1 telehealth

Molecule

Semaglutide · Tirzepatide

Form

Injection

From

From $179/mo

Dose published

No

Prescription

Required

Compounded

Yes — not FDA-approved

Pharmacy

Not named

Omzo runs six categories. Weight loss and sexual health are live. Hormone health, hair, skin and daily health are marked coming soon. A reader is looking at a partly finished catalog.

1.  ## Who writes the prescription, and what do they see?
    
    Omzo states it is not a medical practice and employs no providers. Clinicians come from third-party networks and make the prescribing decision. The site says the assessment creates no doctor-patient relationship. No clinician is named and no state licensure list is published.
    
    A short intake, a clinician review, then delivery in discreet packaging. Support runs through an app. Omzo says it collects the medication cost in its own fee and pays the pharmacies itself. That is cleaner than a separate pharmacy bill.
    
2.  ## What happens when the dose goes up?
    
    Nothing on the site describes what happens as the dose climbs. No milligram is published beside either figure. Whether $179 holds at a higher dose is not stated either way, so the ladder is simply absent here.
    
3.  ## What the price includes
    
    $179 starts compounded semaglutide and $279 starts compounded tirzepatide, both as one weekly injection. Both are described as starting figures rather than flat ones. The branded route is the exception to that framing. Omzo does not sell, dispense or ship branded drugs. Their cost falls outside anything quoted here.
    
4.  ## What it claims, and what it cites
    
    The primary program is compounded, prepared by a state-licensed sterile compounding pharmacy, and not FDA-approved. The FDA has not reviewed it for safety, effectiveness or quality. The pharmacy is not named. Omzo also states that 95 percent of its ingredients are quality-tested for purity and potency, which leaves the remainder unaccounted for.
    

## Where it holds up, and where it does not

-   Strength: Both GLP-1 rates published without an intake
-   Strength: Medication cost stated to be inside the fee
-   Strength: The branded exclusion is disclosed in writing
-   Strength: Compounding status stated in plain terms
-   Limitation: Four of six categories are not open yet
-   Limitation: No milligram appears beside either price
-   Limitation: The compounding pharmacy is not named
-   Limitation: A branded prescription leaves the buyer paying twice over
-   Limitation: The 95 percent testing claim leaves 5 percent unexplained

## What the evidence says about this kind of treatment

The assessment above is about Omzo. These are about the drugs it sells, and they are traced to the primary literature.

-   [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1)
-   [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1)
-   [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain)

Right for

A buyer who wants one fee covering the consult, the medication and the shipping.

Wrong for

A buyer who expects a branded drug to be supplied by the site that prescribes it.

## The evidence behind what Omzo prescribes

These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.

-   [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review)
    
    A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
    
-   [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better)
    
    In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
    

## How Omzo compares

| Seller | Who it suits | Go |
| --- | --- | --- |
| NativeMed | Buyers who want to see the prepay arithmetic before deciding it is a saving |  |
| LumiMeds | Buyers who want the ingredient, route and pharmacy type labeled before they pay |  |
| Mondae | Buyers who want a low published compounded rate and few other details |  |

[Compare all providers side by side →](https://thisglp.com/best)

More GLP-1 telehealth sellers reviews: [Vaylen](https://thisglp.com/reviews/vaylen) [Velvet Rx](https://thisglp.com/reviews/velvet-rx) [VevaRX](https://thisglp.com/reviews/vevarx) [VigorMeds](https://thisglp.com/reviews/vigormeds) [VirtualCare2Go](https://thisglp.com/reviews/virtualcare2go) [Vita Bella](https://thisglp.com/reviews/vita-bella)

Sponsored alternative

SkinnyRx

Readers choosing tirzepatide, the one line with a published standing rate

## Frequently asked

Does the $179 include the medication?

Omzo states medication costs are included in the fees it collects and that it pays the pharmacies itself.

What if a provider prescribes a branded drug?

Omzo does not sell, dispense or ship branded medications. Filling and paying for that prescription is the patient's responsibility.

Is the dose published?

No. Neither product page carries a milligram, and no rate is given for a higher dose.

Is Omzo expensive compared with other GLP-1 telehealth sellers?

Omzo publishes a starting figure of $179/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Omzo below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.

Or [compare every seller we cover](https://thisglp.com/best).

**Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).
